Total debt has held near $2.7 to $2.9 billion while equity rose from $1.8 billion to $2.7 billion, lowering the debt-to-equity ratio from 1.16 to 0.79 and suggesting deleveraging through retained earnings rather than debt repayment.
Encompass Health Corporation (EHC) balance sheet — 30-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Current Assets | 1.01B | 905.9M | 886.9M | 841.8M | 717.2M | 921.4M | 948.6M | 755.8M | 662.1M | 702.2M | 654.5M | 598.7M | 686.6M | 580.4M | 636.8M | 391M | 406.2M | 426M | 682.7M | 637.4M | 880.3M | 874.25M | 1.21B | 1.28B | 797.6M | 1.74B | 1.43B | 1.27B | 1.35B | 1.08B | 847.51M |
| Cash & Short-Term Investments | 76.2M | 145.1M | 85.4M | 141.8M | 21.8M | 49.4M | 224M | 94.8M | 69.2M | 54.4M | 40.5M | 61.6M | 66.7M | 64.5M | 132.8M | 45.1M | 66.6M | 83.6M | 52.5M | 48.7M | 78.1M | 199.34M | 453.77M | 472.78M | 90.7M | 278.46M | 180.41M | 132.88M | 142.51M | 152.4M | 151.79M |
| Cash Only | 76.2M | 102.9M | 85.4M | 104.2M | 21.8M | 49.4M | 224M | 94.8M | 69.2M | 54.4M | 40.5M | 61.6M | 66.7M | 64.5M | 132.8M | 30.1M | 48.4M | 80.9M | 32.2M | 19.8M | 40.6M | 175.5M | 453.77M | 472.78M | 90.7M | 276.58M | 180.32M | 129.4M | 138.83M | 148.07M | 148.03M |
| Short-Term Investments | 0 | 42.2M | 0 | 37.6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15M | 18.2M | 2.7M | 20.3M | 28.9M | 37.5M | 23.84M | 0 | 0 | 0 | 1.87M | 90K | 3.48M | 3.69M | 4.33M | 3.76M |
| Accounts Receivable | 712M | 619.2M | 598.8M | 611.6M | 536.8M | 502.1M | 563M | 498.7M | 467.7M | 472.1M | 443.8M | 410.5M | 323.2M | 261.8M | 249.3M | 222.8M | 224.9M | 219.7M | 417.7M | 447.7M | 608M | 399.1M | 452.33M | 496.71M | 0 | 1.02B | 946.97M | 937.97M | 956.73M | 765.3M | 540.4M |
| Days Sales Outstanding | 38.79 | 38.08 | 40.68 | 46.5 | 45.06 | 45.65 | 57.62 | 39.53 | 39.91 | 44.03 | 44.47 | 48.09 | 49.69 | 42.52 | 42.62 | 40.54 | 44.11 | 41.96 | 83.33 | 94.05 | 129.66 | 83.2 | 43.98 | 45.81 | - | 114.6 | 100.16 | 84.07 | 87.17 | 89.44 | 74.48 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 59M | 62.4M | 60.9M | 45.9M | 234M | 191.4M | 186.8M | 0 | 0 | 0 | 178.2M | 88.5M | 138.7M | 194.89M | 45.47M | -112.35M | 0 | 112.35M | 92.94M | 85.55M | 77.84M | 64.03M | 47.11M |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | 135.7 | 152.55 | 158.78 | 130.17 | 763.27 | 662.82 | 665.84 | - | - | - | 1.33K | 322.06 | 54.71 | 77.78 | - | - | - | - | - | - | - | 11.97 | 10.01 |
| Other Current Assets | 224.8M | 87.7M | 160.4M | 53.9M | 123.7M | 255M | 75.2M | 64.8M | 59M | 62.4M | 60.9M | 45.9M | 234M | 191.4M | 186.8M | 71.5M | 64.6M | 68.3M | 34.4M | 116.1M | 56.4M | 88.3M | 260.58M | 266.24M | 706.9M | 0 | 0 | 0 | 0 | 23.72M | 20.9M |
| Total Non-Current Assets | 6.55B | 6.18B | 5.65B | 5.26B | 4.92B | 5.94B | 5.5B | 5.32B | 4.57B | 4.19B | 4.03B | 4.01B | 2.72B | 1.95B | 1.79B | 1.88B | 1.97B | 1.26B | 1.32B | 1.41B | 2.48B | 2.72B | 2.87B | 2.92B | 3.74B | 5.84B | 5.95B | 5.56B | 5.43B | 4.32B | 2.52B |
| Property, Plant & Equipment | 4.67B | 4.31B | 3.85B | 3.51B | 3.15B | 2.77B | 2.45B | 2.24B | 1.63B | 1.52B | 1.39B | 1.31B | 1.02B | 910.5M | 748M | 664.4M | 685.4M | 664.8M | 674.3M | 744.4M | 1.1B | 1.21B | 1.41B | 1.47B | 0 | 2.77B | 2.87B | 2.5B | 2.29B | 1.85B | 1.39B |
| Fixed Asset Turnover | 1.41x | 1.38x | 1.40x | 1.37x | 1.38x | 1.45x | 1.45x | 2.06x | 2.62x | 2.58x | 2.62x | 2.38x | 2.33x | 2.47x | 2.85x | 3.02x | 2.72x | 2.87x | 2.71x | 2.33x | 1.56x | 1.45x | 2.67x | 2.70x | - | 1.17x | 1.20x | 1.63x | 1.75x | 1.69x | 1.90x |
| Goodwill | 1.32B | 1.32B | 1.28B | 1.28B | 1.26B | 1.24B | 2.32B | 2.31B | 2.1B | 1.97B | 1.93B | 1.89B | 1.08B | 456.9M | 437.3M | 421.7M | 431.3M | 416.4M | 414.7M | 406.1M | 896.9M | 911.4M | 911.09M | 903M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 301.5M | 308.3M | 297.8M | 278.2M | 282.3M | 158.4M | 431.3M | 476.3M | 443.4M | 403.1M | 411.3M | 419.4M | 306.1M | 88.2M | 73.2M | 57.7M | 48.8M | 37.4M | 42.8M | 26.1M | 54.1M | 54.25M | 64.72M | 82.03M | 0 | 1.02B | 946.97M | 937.97M | 956.73M | 765.3M | 540.4M |
| Long-Term Investments | 238.3M | 129.1M | 122.5M | 109.5M | 152.4M | 222.5M | 5.5M | 7.4M | 74.2M | 56.1M | 46.5M | 51.8M | 9.4M | 20.3M | 20.8M | 29M | 30.7M | 29.3M | 37M | 43M | 38M | 46M | 41.05M | 49.55M | 0 | 0 | 0 | 3.84M | 0 | 0 | 0 |
| Other Non-Current Assets | 256.4M | 114.6M | 96.7M | 82.1M | 69.7M | 1.55B | 289.5M | 300.2M | 216.8M | 179M | 174.8M | 145.2M | 173.6M | 123.8M | 114.6M | 99.3M | 90.4M | 97.6M | 183.7M | 236.6M | 432.3M | 545.8M | 448.95M | 390.92M | 3.74B | 342.94M | 230.9M | 178.57M | 177.85M | 223.72M | 83.91M |
| Total Assets | 7.57B | 7.09B | 6.53B | 6.1B | 5.64B | 6.86B | 6.45B | 6.08B | 5.23B | 4.89B | 4.68B | 4.61B | 3.41B | 2.53B | 2.42B | 2.27B | 2.37B | 1.68B | 2B | 2.05B | 3.36B | 3.59B | 4.08B | 4.2B | 4.54B | 7.58B | 7.38B | 6.83B | 6.77B | 5.4B | 3.37B |
| Asset Turnover | 0.86x | 0.84x | 0.82x | 0.79x | 0.77x | 0.58x | 0.55x | 0.76x | 0.82x | 0.80x | 0.78x | 0.68x | 0.70x | 0.89x | 0.88x | 0.88x | 0.78x | 1.14x | 0.92x | 0.85x | 0.51x | 0.49x | 0.92x | 0.94x | 0.78x | 0.43x | 0.47x | 0.60x | 0.59x | 0.58x | 0.79x |
| Asset Growth % | 38.72% | 8.49% | 7.08% | 8.27% | -17.89% | 6.5% | 6.01% | 16.32% | 6.82% | 4.52% | 1.65% | 35.12% | 34.5% | 4.56% | 6.72% | -4.25% | 41.07% | -15.85% | -2.56% | -38.96% | -6.48% | -12.02% | -2.7% | -7.5% | -40.14% | 2.69% | 8.02% | 0.88% | 25.4% | 60.18% | 37.06% |
| Total Current Liabilities | 927.4M | 836.4M | 841M | 656.4M | 575.9M | 748.8M | 717.3M | 721M | 672.5M | 517.5M | 475.6M | 426.4M | 364.3M | 311.6M | 300.9M | 313.2M | 359.3M | 391.2M | 746.2M | 970.5M | 1.26B | 1.11B | 1.2B | 1.11B | 1.29B | 359M | 382.91M | 418.19M | 401.06M | 516.45M | 303.54M |
| Accounts Payable | 231.4M | 178.2M | 171M | 170M | 132.9M | 134M | 115M | 94.6M | 90M | 78.4M | 68.3M | 61.6M | 53.4M | 61.9M | 45.3M | 45.4M | 48.9M | 50.2M | 45.5M | 48.7M | 67.5M | 121.2M | 94.95M | 122.08M | 0 | 37.09M | 78.76M | 76.55M | 76.1M | 125.8M | 116.5M |
| Days Payables Outstanding | 19.56 | 19.3 | 19.88 | 22.02 | 18.69 | 21.16 | 245.47 | 205.65 | 206.99 | 191.67 | 178.07 | 174.7 | 174.18 | 214.36 | 161.47 | 161.2 | 179.56 | - | 340.32 | 177.22 | 26.63 | 48.37 | - | - | - | - | - | - | - | 23.52 | 24.75 |
| Short-Term Debt | 47.8M | 70.1M | 114.9M | 48.9M | 25.2M | 18.7M | 14.5M | 18.3M | 35.8M | 32.3M | 37.1M | 36.8M | 20.8M | 12.3M | 13.6M | 18.9M | 14.5M | 21.5M | 24.8M | 68.3M | 37M | 34.3M | 299.84M | 426.51M | 0 | 21.91M | 43.23M | 37.82M | 49.99M | 46.49M | 35.41M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 212.8M | 196.8M | 173.1M | 155.9M | 144.5M | 114.6M | 111.6M | 107.5M | 101.5M | 130.9M | 97.9M | 93.2M | 167.1M | 163.72M | 169.26M | -1.14M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 588.1M | 505.1M | 230M | 181.1M | 264.1M | 174.3M | 162.7M | 292.6M | 149.1M | 136.1M | 131.6M | 110M | 80.7M | 156.3M | 156.6M | 215.9M | 241.6M | 586.1M | 760.7M | 1B | 839.63M | 640.14M | 408.69M | 0 | 99.87M | 4.23M | 108.17M | 37.61M | 136.24M | 10.73M |
| Current Ratio | 1.09x | 1.08x | 1.05x | 1.28x | 1.25x | 1.23x | 1.32x | 1.05x | 0.98x | 1.36x | 1.38x | 1.40x | 1.88x | 1.86x | 2.12x | 1.25x | 1.13x | 1.09x | 0.91x | 0.66x | 0.70x | 0.79x | 1.01x | 1.15x | 0.62x | 4.84x | 3.74x | 3.04x | 3.36x | 2.10x | 2.79x |
| Quick Ratio | 1.09x | 1.08x | 1.05x | 1.28x | 1.25x | 1.23x | 1.32x | 1.05x | 0.90x | 1.24x | 1.25x | 1.30x | 1.24x | 1.25x | 1.50x | 1.25x | 1.13x | 1.09x | 0.68x | 0.57x | 0.59x | 0.61x | 0.97x | 1.25x | 0.62x | 4.52x | 3.49x | 2.83x | 3.16x | 1.97x | 2.64x |
| Cash Conversion Cycle | 19.23 | - | - | - | - | - | - | - | -31.39 | 4.91 | 25.18 | 3.56 | 638.77 | 490.98 | 546.99 | - | - | - | 1.08K | 238.88 | 157.74 | 112.61 | - | - | - | - | - | - | - | 77.89 | 59.74 |
| Total Non-Current Liabilities | 3.08B | 2.98B | 2.84B | 3.15B | 3.2B | 3.72B | 3.73B | 3.43B | 2.68B | 2.73B | 3.14B | 3.28B | 2.25B | 1.65B | 1.38B | 1.76B | 2.02B | 2.19B | 2.34B | 2.54B | 4.01B | 3.75B | 3.75B | 3.82B | 3.77B | 3.27B | 3.33B | 3.08B | 2.82B | 1.63B | 1.48B |
| Long-Term Debt | 2.55B | 2.18B | 2.06B | 2.37B | 2.74B | 2.85B | 2.85B | 2.63B | 2.48B | 2.55B | 2.98B | 3.13B | 2.11B | 1.51B | 1.24B | 1.24B | 1.5B | 1.64B | 1.79B | 1.97B | 3.37B | 3.37B | 3.04B | 3.13B | 0 | 3.01B | 3.17B | 3.08B | 2.78B | 1.57B | 1.51B |
| Capital Lease Obligations | 1.49B | 464.7M | 484.4M | 514.6M | 199.7M | 568.8M | 605.5M | 634.9M | 0 | 0 | 0 | 276.3M | 0 | 88.9M | 0 | 0 | 0 | 0 | 115.9M | -387.4M | 112.5M | 0 | 182.77M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -62.48M |
| Deferred Tax Liabilities | 521.3M | 126.8M | 105.2M | 87M | 83M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29.7M | 29.8M | 80M | 47.47M | 28.75M | -51.34M | 0 | 259.54M | 160.37M | 0 | 28.86M | 76.61M | 28.8M |
| Other Non-Current Liabilities | 222.8M | 206.9M | 190.4M | 177.9M | 174.2M | 296.8M | 266.8M | 159.9M | 205.2M | 185.3M | 160M | -131.7M | 136.3M | 53.3M | 136.7M | 520.6M | 518.2M | 546.9M | -370.8M | -241.6M | 60.9M | 332.15M | 498.92M | 694.32M | 0 | 4.21M | 4.13M | 4.57M | 11.94M | -8.93M | -58.92M |
| Total Liabilities | 4.01B | 3.81B | 3.69B | 3.81B | 3.77B | 4.47B | 4.44B | 4.15B | 3.36B | 3.25B | 3.61B | 3.71B | 2.61B | 1.96B | 1.68B | 2.07B | 2.37B | 2.58B | 3.09B | 3.51B | 5.27B | 4.86B | 4.95B | 4.93B | 5.07B | 3.63B | 3.72B | 3.5B | 3.22B | 2.15B | 1.79B |
| Total Debt | 2.8B | 2.71B | 2.71B | 2.93B | 2.99B | 3.48B | 3.54B | 3.35B | 2.51B | 2.58B | 3.02B | 3.17B | 2.13B | 1.52B | 1.25B | 1.25B | 1.51B | 1.66B | 1.81B | 2.04B | 3.4B | 3.4B | 3.53B | 3.55B | 3.6B | 3.03B | 3.21B | 3.11B | 2.83B | 1.6B | 1.49B |
| Net Debt | 2.73B | 2.61B | 2.63B | 2.83B | 2.97B | 3.43B | 3.32B | 3.25B | 2.45B | 2.52B | 2.98B | 3.11B | 2.06B | 1.45B | 1.12B | 1.22B | 1.46B | 1.58B | 1.78B | 2.02B | 3.36B | 3.23B | 3.08B | 3.08B | 3.51B | 2.75B | 3.03B | 2.99B | 2.69B | 1.45B | 1.34B |
| Debt / Equity | 0.79x | 0.83x | 0.95x | 1.28x | 1.61x | 1.45x | 1.77x | 1.73x | 1.34x | 1.57x | 2.83x | 3.52x | 2.67x | 2.64x | 1.68x | 6.22x | - | - | - | - | - | - | - | - | - | 0.77x | 0.88x | 0.93x | 0.80x | 0.49x | 0.94x |
| Debt / EBITDA | 1.84x | 1.97x | 2.33x | 2.92x | 3.42x | 3.96x | 4.79x | 3.67x | 2.85x | 3.09x | 3.67x | 4.57x | 3.72x | 2.74x | 2.53x | 2.77x | 3.77x | 4.78x | 3.71x | 7.47x | 19.66x | 14.63x | 8.17x | 59.46x | 0.97x | 0.92x | 0.93x | 1.77x | 1.52x | 3.24x | 4.13x |
| Net Debt / EBITDA | 1.79x | 1.89x | 2.26x | 2.81x | 3.40x | 3.90x | 4.49x | 3.57x | 2.77x | 3.03x | 3.62x | 4.48x | 3.60x | 2.63x | 2.26x | 2.70x | 3.65x | 4.55x | 3.64x | 7.40x | 19.42x | 13.88x | 7.12x | 51.54x | 0.94x | 0.83x | 0.88x | 1.70x | 1.45x | 2.94x | 3.72x |
| Interest Coverage | 9.39x | 8.74x | 6.46x | 5.23x | 3.57x | 4.07x | 2.92x | 4.52x | 4.35x | 4.22x | 3.80x | 3.77x | 4.54x | 4.94x | 4.61x | 3.03x | 2.51x | 1.98x | 2.23x | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 3.56B | 3.28B | 2.85B | 2.3B | 1.86B | 2.4B | 2B | 1.93B | 1.87B | 1.65B | 1.07B | 900.4M | 797.4M | 575.4M | 746.3M | 201.6M | -2.2M | -897.6M | -1.09B | -1.46B | -1.91B | -1.27B | -865.44M | -737.46M | -528.8M | 3.95B | 3.66B | 3.33B | 3.55B | 3.25B | 1.59B |
| Equity Growth % | 53.44% | 14.97% | 24.03% | 23.38% | -22.39% | 19.86% | 3.56% | 3.29% | 13.71% | 54.22% | 18.5% | 12.92% | 38.58% | -22.9% | 270.19% | 9263.64% | 99.75% | 17.44% | 25.4% | 23.84% | -51.03% | -46.4% | -17.35% | -39.46% | -113.38% | 7.83% | 9.95% | -6.13% | 9.2% | 105.09% | 67.13% |
| Book Value per Share | 35.72 | 32.05 | 27.88 | 22.68 | 18.54 | 23.94 | 20.06 | 19.44 | 18.75 | 16.57 | 10.72 | 8.91 | 7.92 | 5.64 | 6.90 | 1.85 | -0.02 | -8.69 | -11.28 | -15.84 | -21.19 | -15.92 | -10.88 | -9.09 | -6.47 | 47.59 | 46.81 | 40.20 | 41.06 | 40.81 | 24.10 |
| Total Shareholders' Equity | 2.68B | 2.44B | 2.07B | 1.65B | 1.31B | 1.91B | 1.59B | 1.35B | 1.33B | 1.18B | 735.9M | 611.4M | 566.4M | 437.8M | 633.8M | 117M | -85.2M | -974M | -1.17B | -1.55B | -2.18B | -1.54B | -1.11B | -963.84M | -528.8M | 3.8B | 3.53B | 3.21B | 3.42B | 3.16B | 1.52B |
| Common Stock | 0 | 1.2M | 1.2M | 1.2M | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | 1.1M | 611.4M | 473.2M | 344.6M | 1M | 1M | 1M | 1M | 1M | 900K | 900K | 4.41M | 4.39M | 4.39M | 0 | 4.3M | 4.26M | 4.24M | 4.23M | 3.95M | 3.19M |
| Retained Earnings | 0 | 1.29B | 796.7M | 406.5M | 115.7M | 141.8M | -242.3M | -526.5M | -885.2M | -1.19B | -1.45B | -1.7B | -1.88B | -2.1B | -2.42B | -2.61B | -2.82B | -3.72B | -3.81B | -4.06B | -4.71B | -4.09B | -3.64B | -3.47B | 0 | 1.43B | 1.22B | 948.38M | 878.23M | 853.64M | 536.42M |
| Treasury Stock | 0 | -722.5M | -577.9M | -547.2M | -536.7M | -521.2M | -497.4M | -492.3M | -427.9M | -418.5M | -614.7M | -527.4M | -458.7M | -404.6M | -163.3M | -148.8M | -141.8M | -137.5M | -311.5M | -310.4M | -322.7M | -307.1M | -307.91M | -307.75M | 0 | -280.52M | -280.52M | -278.5M | -21.81M | -323K | -323K |
| Accumulated OCI | 0 | 500K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.3M | -1.2M | -1.2M | -500K | -100K | 1.4M | -200K | 500K | -387.4M | -3.2M | -800K | 1.5M | -1.17M | 308K | -943K | 0 | 13.91M | 1.66M | -7.9M | 0 | -12.25M | 0 |
| Minority Interest | 880M | 837.6M | 782.2M | 649.7M | 551.6M | 487.9M | 413.6M | 580.5M | 542M | 463.8M | 331.1M | 289M | 231M | 137.6M | 112.5M | 84.6M | 83M | 76.4M | 82.2M | 97.2M | 271.1M | 273.74M | 243.98M | 226.38M | 0 | 154.54M | 137.98M | 126.38M | 127.22M | 93.69M | 69.26M |
Quick answers to the most common questions about buying EHC stock.
As of 2025, Encompass Health Corporation (EHC) had total assets of $7.09B including $905.9M in current assets.
Encompass Health Corporation (EHC) carries total debt of $2.71B, offset by $145.1M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Encompass Health Corporation (EHC) has total shareholders' equity (book value) of $2.44B ($32.05 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Encompass Health Corporation (EHC) reported a current ratio of 1.08x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Government payer reimbursement concentration
Metrics are mathematically derived from official filings.
Equity Rebuilding Alongside Asset Growth
Based on EHC's reported figures, total assets rose from $6.4 billion to $7.6 billion over ten quarters while equity climbed from $1.8 billion to $2.7 billion, suggesting the balance sheet is strengthening through retained earnings rather than leverage.
The steady rise in retained earnings from $602.3 million to roughly $1.6 billion indicates that profits are being retained and reinvested, which appears to reflect a maturing capital base. Total liabilities have stayed near $3.7 to $4.0 billion, so asset growth has been funded primarily by internal accumulation, which may indicate improving balance sheet quality. Investors should monitor whether this pattern persists once the post-spin-off capital structure fully settles.
Leverage Declining Despite Stable Debt Base
As reported in financial statements, EHC's total debt held near $2.7 to $2.9 billion while its debt-to-equity ratio fell from 1.16 to 0.79, reflecting equity growth rather than debt reduction.
Because gross debt has been essentially flat, the improvement in the D/E ratio is driven almost entirely by the expanding equity base, which may indicate that leverage is becoming less burdensome relative to book capital. The reported D/E of 0.79 in the latest quarter also appears low for a capital-intensive hospital operator, which warrants verification against filings given the earlier data inconsistency. Investors should monitor whether debt levels remain flat as capex needs for de novo expansion grow.
Fixed Asset Base Anchors Hospital Footprint
According to recent SEC filings, EHC's net PPE grew from $3.7 billion to $4.7 billion while goodwill held constant near $1.3 billion, suggesting the asset base is weighted toward physical hospital infrastructure.
The growth in net PPE is consistent with the ongoing de novo hospital and bed expansion program, and the flat goodwill balance indicates limited reliance on acquisition-driven value. Because hospital real estate and equipment are capital-intensive and slow to monetize, the asset mix may make the business less flexible in a downturn. Goodwill represents roughly 17 percent of total assets, which appears manageable but warrants monitoring for impairment risk if acquired facilities underperform.
Thin Cash Cushion Against Current Obligations
Based on EHC's reported figures, cash ranged between $49 million and $198 million over the period while the current ratio held between 1.04 and 1.35, suggesting liquidity relies on operating cash flow rather than a large cash reserve.
Cash balances are modest relative to total assets of $7.6 billion, and the current ratio near 1.1 to 1.2 indicates only a limited margin above short-term obligations. Given strong operating cash conversion, the company appears to depend on ongoing cash generation to meet near-term needs, which may leave less room for shocks. Investors should monitor whether the current ratio stabilizes above 1.0 as capital spending continues.
Reimbursement Concentration Obscures Balance Sheet Strength
As reported in the company's disclosures, roughly three-quarters of revenue is tied to government payers, so headline balance sheet improvement may depend heavily on continued CMS rate stability.
The improvement in equity and reduction in D/E could be misleading if reimbursement rates are reset downward, since retained earnings growth is ultimately derived from government-set pricing. A rate reset would compress the cash flows that currently fund both capex and capital returns, which may reverse the trajectory of the balance sheet. This dependence suggests that the reported strength warrants investigation of payer mix sensitivity rather than being treated as independently durable.